Skip to main content
I.Ceram logo

I.Ceram — Investor Relations & Filings

Ticker · ALICR ISIN · FR0011511971 LEI · 969500R28RHD3HDEIL86 PA Manufacturing
Open in API
Filings indexed 157 across all filing types
Latest filing 2018-02-27 Regulatory Filings
Country FR France
Listing PA ALICR

About I.Ceram

https://www.iceram.fr/

I.Ceram specializes in the design, manufacture, and marketing of orthopedic and reconstructive implants. The company's core technology is centered on porous alumina bioceramics, though it also utilizes metals and polymers. A key innovation is the development of active implants, such as its Ceramil line, which can be loaded with antibiotics like gentamicin. This feature enables the localized delivery of medication directly to bone tissue to prevent and treat infections post-surgery. The product portfolio includes implants for various joints and a bioceramic sternal implant designed for reconstructive procedures.

Recent filings

Filing Released Lang Actions
Formation de chirurgiens européens à la technique opératoire de l’implant sternal Ceramil
Regulatory Filings Classification · 1% confidence The document is a press release detailing a workshop where a company (I.CERAM) presented its new medical implant (CERAMIL) to European surgeons. It discusses clinical experience, upcoming commercial launch, and regulatory milestones (CE marking expected). This content is promotional and informational regarding the company's product development and market readiness, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific shareholder communication (like DEF 14A or DVA). Since it is an announcement about company activities, product updates, and market positioning, and does not fit the specific categories like M&A (TAR), Financing (CAP), or Director Dealing (DIRS), it best fits the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, or potentially 'Investor Presentation' (IP) if it were the presentation itself, but this reads like a news release about an event. Given the options, RNS serves as the best general corporate announcement fallback for non-standard disclosures.
2018-02-27 French
Eligibilité d’I.CERAM au dispositif PEA-PME 2018
Fund Information / Factsheet Classification · 1% confidence The document is a very short announcement (1794 characters) confirming I.Ceram's eligibility for the PEA-PME investment scheme based on its 2016 annual accounts. It details the criteria for eligibility (employee count, revenue/balance sheet limits) and provides company background and investor relations contacts. It is not a full financial report (like 10-K or IR), nor is it a standard earnings release (ER) or management discussion (MDA). Since it is a specific regulatory/financial status announcement that doesn't fit the primary categories like DIV, CAP, or DIRS, and it is an announcement rather than the full report itself, it best fits the general 'Regulatory Filings' category (RNS) as a miscellaneous, specific regulatory update concerning its status for French investment schemes.
2018-02-26 French
Bilan semestriel du contrat de liquidité fin 2017
Capital/Financing Update Classification · 1% confidence The document is titled "Bilan semestriel du contrat de liquidité" (Semi-annual balance sheet of the liquidity contract) and details the holdings (shares and cash) in a liquidity account managed by Louis Capital Markets as of 29/12/2017, comparing it to the previous balance on 30/06/2017. This document relates to the management of the company's own shares or market stabilization activities, which falls under the scope of 'Transaction in Own Shares' (POS) or potentially a specific regulatory filing. Since it details the status of a liquidity contract (often related to share buybacks or stabilization), POS is the most specific fit. It is not a full financial report (10-K or IR), an earnings release (ER), or a dividend notice (DIV). Given the context of managing a liquidity contract, POS (Transaction in Own Shares) is the appropriate classification.
2018-01-15 French
I.CERAM participe au salon ACTIONARIA les 23 et 24 novembre 2017
Regulatory Filings Classification · 1% confidence The document is a short announcement from I.CERAM stating its participation in the ACTIONARIA trade show on November 23rd and 24th, 2017. It details the purpose (dialogue with individual investors, discussing strategy) and mentions specific presentation times for the CEO. This is not a formal regulatory filing (like 10-K, IR, ER), nor is it a report itself. It is an announcement about management/company presence at an investor event, which aligns best with general investor relations communication, but given the specific options, it is an announcement regarding investor engagement and company updates, which is often covered under general investor communications or potentially a specific event announcement. Since there is no specific 'Investor Event Announcement' code, and it involves management interaction with shareholders/investors, it is closest to general Investor Relations communication. However, looking closely at the definitions, it is an announcement about management/company activity aimed at investors, but it doesn't fit perfectly into the provided codes like AGM-R (it's not the AGM itself), ER, or IP. Given the context of meeting shareholders and discussing strategy, it is a form of investor communication. Since it is a brief announcement about company activity and management presence at an event, and not a formal report or a change in management structure (MANG), the most appropriate general category for non-standard investor news that isn't a formal report or dividend notice is often RNS (Regulatory Filings/General Announcement) or potentially a very broad interpretation of Investor Presentation (IP) if it were a presentation, but here it's an announcement *about* attending an event. Given the content focuses on meeting shareholders and discussing strategy at a public event, and it's a short announcement, RNS is the safest fallback for non-standard investor news, although it strongly relates to investor engagement. Re-evaluating: It is an announcement about management engaging with investors at a public forum. This is not a standard filing. I will classify it as RNS (Regulatory Filings) as a general announcement that doesn't fit the specific report types.
2017-11-20 French
First antibiotic loaded ceramic implanted in femur for bone replacement
Regulatory Filings Classification · 1% confidence The document describes a specific medical procedure (implantation of an antibiotic-loaded ceramic in a femur) performed by I.Ceram, detailing the patient case, the technology used (CERAMIL®), and the positive outcome. It is a press release or news item announcing a significant operational milestone or success story related to the company's products. This type of announcement, focusing on product application and success rather than mandatory financial reporting (like 10-K, ER, IR) or governance changes (like MANG, DIRS), typically falls under general Regulatory Filings (RNS) or potentially Investor Relations material if it were a presentation (IP). Since it is a general announcement of a successful case study/product use, and does not fit the specific financial or governance codes, RNS is the most appropriate general regulatory/news category.
2017-11-08 English
1ère pose d’un implant chargé en antibiotiques dans un fémur
Regulatory Filings Classification · 1% confidence The document describes a specific medical procedure involving an antibiotic-loaded ceramic implant by the company I.CERAM. It details a successful case study (a patient operation in 2017) and highlights the company's expertise and strategy. This content is not a standard regulatory filing (like 10-K, ER, or IR), nor is it a management change, dividend announcement, or voting result. It reads like a press release or a news item announcing a significant operational achievement or product application success. Since there is no specific category for 'Press Release' or 'Case Study,' and the content is informational/promotional about a company event/achievement, the most appropriate fallback category is 'Regulatory Filings' (RNS), which often serves as a catch-all for general corporate announcements that don't fit the highly specific financial or governance categories provided.
2017-11-08 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.